The PennZone

  • Home
  • Entertainment
  • Marketing
  • Books
  • Non-profit
  • Music
  • Education
  • Legal
  • Artificial Intelligence

Lineus Medical Receives Innovative Technology Contract from Vizient for SafeBreak® Vascular
The PennZone/10180170

Trending...
  • RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
  • Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
  • Award-Winning Author's New Timely Book "Philly Girl" Highlights Centuries of Brave & Bold Women from Philadelphia
Lineus Medical
Contract awarded for products that bring improvement to health care industry

FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announced its SafeBreak® Vascular has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of SafeBreak Vascular by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.

More on The PennZone
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
  • MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
  • Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year

"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.

"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

More on The PennZone
  • September Is Healthy Aging® Month Announces 2026 Theme: "Curiosity Has No Age Limit"
  • Lake Norman Philharmonic - Free Community Concert
  • Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million

###

Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.

1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.

MKG-0135 Rev. 00

Source: Lineus Medical

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
  • Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING
  • Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
  • 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
  • MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C
  • Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
  • Award-Winning Author's New Timely Book "Philly Girl" Highlights Centuries of Brave & Bold Women from Philadelphia
  • RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
  • National Nonprofit Lights 200 Landmarks Pink and Blue for Pregnancy and Infant Loss Awareness Month
  • Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
  • Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
  • Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor
  • When Hope Feels Gone, Death2life Is Still Here!
  • Sebastian Stroeller Publishes "The MAP Language Canon" — The Complete Practitioner's Guide to Structural Conversation
  • OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors
  • GLADYS Magazine Celebrates their 18 Year Anniversary!
  • New Townhome Building Released at Heritage at South Brunswick, Offering Private Perimeter Setting and Water Views
  • Comics Veteran on Return of Teenage Mutant Ninja Turtles Characters, 3-D Projects, Collaboration with Original 'Star Wars' Toy Engineer
  • Flexible Plan Investments Announces Retirement of Executive Vice President Renée Toth
  • Sensory Education launches new neuro-affirming psychoeducation book, Sensory Diversity

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 1591
  • Easwe Lightweight Electric Wheelchair Collection with Travel-Focused Mobility Solutions - 179
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man - 172
  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 154
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event - 144
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers - 134
  • INAD Warriors' 4th Annual "Dancing with the INAD Stars" Gala - 126
  • Michael Fischer, President and CEO of Client 1st Financial, Named to LVB 300 - 112
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd - 112
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 101

Similar on PennZone

  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
  • September Is Healthy Aging® Month Announces 2026 Theme: "Curiosity Has No Age Limit"
  • Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
  • Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing
  • National Nonprofit Lights 200 Landmarks Pink and Blue for Pregnancy and Infant Loss Awareness Month
  • Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
  • Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us